vs
Madison Square Garden Entertainment Corp.（MSGE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Madison Square Garden Entertainment Corp.的季度营收约是Orthofix Medical Inc.的1.9倍（$424.8M vs $219.9M），Madison Square Garden Entertainment Corp.净利率更高（21.8% vs -1.0%，领先22.8%），Madison Square Garden Entertainment Corp.同比增速更快（12.5% vs 2.0%），过去两年Madison Square Garden Entertainment Corp.的营收复合增速更高（48.9% vs 8.0%）
麦迪逊广场花园娱乐公司是总部位于美国纽约的体育控股企业，依托麦迪逊广场花园的核心资源，在体育赛事运营、体育IP管理及相关商业化领域拥有深厚行业积累与广泛影响力。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MSGE vs OFIX — 直观对比
营收规模更大
MSGE
是对方的1.9倍
$219.9M
营收增速更快
MSGE
高出10.5%
2.0%
净利率更高
MSGE
高出22.8%
-1.0%
两年增速更快
MSGE
近两年复合增速
8.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $424.8M | $219.9M |
| 净利润 | $92.7M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 38.6% | 0.2% |
| 净利率 | 21.8% | -1.0% |
| 营收同比 | 12.5% | 2.0% |
| 净利润同比 | 22.2% | 92.4% |
| 每股收益（稀释后） | $1.94 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSGEOFIX
| Q4 25 | $424.8M | $219.9M | ||
| Q3 25 | $154.1M | $205.6M | ||
| Q2 25 | $145.1M | $203.1M | ||
| Q1 25 | $206.0M | $193.6M | ||
| Q4 24 | $377.6M | $215.7M | ||
| Q3 24 | $134.1M | $196.6M | ||
| Q2 24 | $177.6M | $198.6M | ||
| Q1 24 | $191.6M | $188.6M |
净利润MSGEOFIX
| Q4 25 | $92.7M | $-2.2M | ||
| Q3 25 | $-21.7M | $-22.8M | ||
| Q2 25 | $-27.2M | $-14.1M | ||
| Q1 25 | $8.0M | $-53.1M | ||
| Q4 24 | $75.9M | $-29.1M | ||
| Q3 24 | $-19.3M | $-27.4M | ||
| Q2 24 | $66.9M | $-33.4M | ||
| Q1 24 | $2.8M | $-36.0M |
毛利率MSGEOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率MSGEOFIX
| Q4 25 | 38.6% | 0.2% | ||
| Q3 25 | -19.3% | -8.3% | ||
| Q2 25 | -17.7% | -7.9% | ||
| Q1 25 | 13.3% | -25.2% | ||
| Q4 24 | 36.8% | -5.3% | ||
| Q3 24 | -13.8% | -9.6% | ||
| Q2 24 | -5.0% | -12.5% | ||
| Q1 24 | 8.8% | -15.6% |
净利率MSGEOFIX
| Q4 25 | 21.8% | -1.0% | ||
| Q3 25 | -14.0% | -11.1% | ||
| Q2 25 | -18.7% | -6.9% | ||
| Q1 25 | 3.9% | -27.4% | ||
| Q4 24 | 20.1% | -13.5% | ||
| Q3 24 | -14.4% | -13.9% | ||
| Q2 24 | 37.7% | -16.8% | ||
| Q1 24 | 1.5% | -19.1% |
每股收益（稀释后）MSGEOFIX
| Q4 25 | $1.94 | $-0.05 | ||
| Q3 25 | $-0.46 | $-0.57 | ||
| Q2 25 | $-0.56 | $-0.36 | ||
| Q1 25 | $0.17 | $-1.35 | ||
| Q4 24 | $1.56 | $-0.76 | ||
| Q3 24 | $-0.40 | $-0.71 | ||
| Q2 24 | $1.32 | $-0.88 | ||
| Q1 24 | $0.06 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.1M | $82.0M |
| 总债务越低越好 | $554.6M | — |
| 股东权益账面价值 | $36.0M | $450.0M |
| 总资产 | $1.8B | $850.6M |
| 负债/权益比越低杠杆越低 | 15.40× | — |
8季度趋势，按日历期对齐
现金及短期投资MSGEOFIX
| Q4 25 | $157.1M | $82.0M | ||
| Q3 25 | $29.9M | $62.9M | ||
| Q2 25 | $43.0M | $65.6M | ||
| Q1 25 | $89.0M | $58.0M | ||
| Q4 24 | $54.9M | $83.2M | ||
| Q3 24 | $37.3M | $30.1M | ||
| Q2 24 | $33.3M | $26.4M | ||
| Q1 24 | $28.0M | $27.0M |
总债务MSGEOFIX
| Q4 25 | $554.6M | — | ||
| Q3 25 | $581.7M | $157.2M | ||
| Q2 25 | $568.8M | $157.0M | ||
| Q1 25 | $577.4M | $156.9M | ||
| Q4 24 | $584.7M | $157.0M | ||
| Q3 24 | $647.0M | $118.5M | ||
| Q2 24 | $599.2M | $118.0M | ||
| Q1 24 | $602.5M | $118.2M |
股东权益MSGEOFIX
| Q4 25 | $36.0M | $450.0M | ||
| Q3 25 | $-65.8M | $442.5M | ||
| Q2 25 | $-13.3M | $458.3M | ||
| Q1 25 | $9.5M | $458.3M | ||
| Q4 24 | $10.3M | $503.1M | ||
| Q3 24 | $-48.7M | $525.9M | ||
| Q2 24 | $-23.2M | $546.0M | ||
| Q1 24 | $-94.6M | $570.3M |
总资产MSGEOFIX
| Q4 25 | $1.8B | $850.6M | ||
| Q3 25 | $1.7B | $832.6M | ||
| Q2 25 | $1.7B | $837.2M | ||
| Q1 25 | $1.7B | $823.1M | ||
| Q4 24 | $1.6B | $893.3M | ||
| Q3 24 | $1.6B | $867.9M | ||
| Q2 24 | $1.6B | $882.0M | ||
| Q1 24 | $1.5B | $906.0M |
负债/权益比MSGEOFIX
| Q4 25 | 15.40× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | 60.61× | 0.34× | ||
| Q4 24 | 56.61× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $164.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 1.77× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MSGEOFIX
| Q4 25 | $164.4M | $27.7M | ||
| Q3 25 | $19.8M | $12.4M | ||
| Q2 25 | $-27.0M | $11.6M | ||
| Q1 25 | $56.8M | $-18.4M | ||
| Q4 24 | $112.9M | $23.7M | ||
| Q3 24 | $-27.4M | $11.7M | ||
| Q2 24 | $212.0K | $9.0M | ||
| Q1 24 | $5.8M | $-18.6M |
自由现金流MSGEOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率MSGEOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度MSGEOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率MSGEOFIX
| Q4 25 | 1.77× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 7.07× | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 2.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MSGE
| Ticketing And Venue License Fee Revenues | $263.5M | 62% |
| Food Beverage And Merchandise Revenues | $64.3M | 15% |
| Related Party | $43.9M | 10% |
| Arena Licensing Fees And Other Leasing Revenue | $35.2M | 8% |
| Other | $15.9M | 4% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
